Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Cattran

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Journal of the American Society of Nephrology : JASN|February 18, 2005
Focal and segmental glomerulosclerosis: definition and relevance of a partial remissionStéphan Troyanov, Catherine A Wall, Judith A Miller, et al.
Nephron. Clinical Practice|July 30, 2008
Validation of the Toronto formula to predict progression in IgA nephropathyBruce Mackinnon, Emily P Fraser, Daniel C Cattran, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 3, 2007
Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograftKhaled O Alsaad, Ana Tobar, Eric Belanger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 4, 2013
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysisJicheng Lv, Sufang Shi, Damin Xu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2024
Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trialMatthew Kadatz, Scott Klarenbach, Helen So, et al.
Kidney International|August 20, 2015
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritisSean J Barbour, Daniel C Cattran, Gabriela Espino-Hernandez, et al.
Kidney International|March 13, 2003
Interactions between gender and the angiotensin type 1 receptor gene polymorphismHeather Reich, John A Duncan, Jordan Weinstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2008
The impact of sex in primary glomerulonephritisDaniel C Cattran, Heather N Reich, Heather J Beanlands, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2021
Limited Significance of Antifactor H Antibodies in Patients with Membranous NephropathyAmit Sethi, Jing Miao, Maria Alice V Willrich, et al.
Clinical Nephrology|March 27, 2012
Rituximab therapy for Type I membranoproliferative glomerulonephritisJohn J Dillon, Michelle Hladunewich, William E Haley, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Journal of the American Society of Nephrology : JASN|February 18, 2005
Focal and segmental glomerulosclerosis: definition and relevance of a partial remissionStéphan Troyanov, Catherine A Wall, Judith A Miller, et al.
Nephron. Clinical Practice|July 30, 2008
Validation of the Toronto formula to predict progression in IgA nephropathyBruce Mackinnon, Emily P Fraser, Daniel C Cattran, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 3, 2007
Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograftKhaled O Alsaad, Ana Tobar, Eric Belanger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 4, 2013
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysisJicheng Lv, Sufang Shi, Damin Xu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2024
Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trialMatthew Kadatz, Scott Klarenbach, Helen So, et al.
Kidney International|August 20, 2015
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritisSean J Barbour, Daniel C Cattran, Gabriela Espino-Hernandez, et al.
Kidney International|March 13, 2003
Interactions between gender and the angiotensin type 1 receptor gene polymorphismHeather Reich, John A Duncan, Jordan Weinstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2008
The impact of sex in primary glomerulonephritisDaniel C Cattran, Heather N Reich, Heather J Beanlands, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2021
Limited Significance of Antifactor H Antibodies in Patients with Membranous NephropathyAmit Sethi, Jing Miao, Maria Alice V Willrich, et al.
Clinical Nephrology|March 27, 2012
Rituximab therapy for Type I membranoproliferative glomerulonephritisJohn J Dillon, Michelle Hladunewich, William E Haley, et al.
Pageof 11